Cutaneous lymphomas management during COVID-19 pandemic
Ital J Dermatol Venerol
.
2021 Apr;156(2):248-249.
doi: 10.23736/S2784-8671.20.06717-6.
Epub 2020 Oct 21.
Authors
Paola Vitiello
1
,
Antonello Sica
2
,
Andrea Ronchi
3
,
Francesco Pastore
4
,
Beniamino Casale
5
,
Giuseppe Argenziano
1
Affiliations
1
Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples, Italy.
2
Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy - antonello.sica@fastwebnet.it.
3
Unit of Pathology, Department of Mental and Physical Health and Preventive Medicine, Luigi Vanvitelli University of Campania, Naples, Italy.
4
Unit of Radiotherapy, Emicenter, Casavatore, Naples, Italy.
5
Department of Pain, Dei Colli-V. Monaldi Hospital, Naples, Italy.
PMID:
33084270
DOI:
10.23736/S2784-8671.20.06717-6
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Lymphoma, B-Cell / therapy*
Lymphoma, T-Cell, Cutaneous / therapy*
Skin Neoplasms / therapy*